Low-invasive treatment serous bursitis of the elbow joint

62 patients with the diagnosis sharp elbow bursitis during the period with 1998 on 2009 are investigated year. Average age of patients – 34,9±6,5 years. Depending on a way of treatment elbow bursitis patients are divided into two groups. Between groups it wasn't revealed significant distinctions on a sex, age, character of accompanying pathology. Application of the developed way of treatment elbow bursitis with introduction of sklerozant it is economic in view of reduction of terms of temporary disability on the average twice.